BASIC

Basic Pharma is an independent pharmaceutical group based in the Netherlands that specializes in the development, licensing, manufacturing, and commercialization of pharmaceutical and biopharmaceutical products. The company operates as a full-service CDMO, offering expertise in semi-solid and liquid formulations, including sterile preparations and high-potency compounds. Its biotech department focuses on the custom development and production of recombinant proteins for research, diagnostics, and preclinical applications. Basic Pharma also maintains an internal pipeline of generic and innovative medicines, including projects targeting skin cancer through its SKiN-HUID collaboration. With GMP-certified facilities at the Brightlands Chemelot Campus, the group serves a global clientele ranging from academic institutions to major pharmaceutical companies.